ANRO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Alto Neuroscience, Inc. and Encourages Investors to Contact the Firm
Alto Neuroscience, Inc. (ANRO)
Company Research
Source: GlobeNewswire
NEW YORK, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alto Neuroscience, Inc. (“Alto Neuroscience” or “the Company”) (NYSE: ANRO). Investors who purchased Alto Neuroscience securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ANRO. Investigation Details On October 22, 2024, Alto Neuroscience announced that “the Phase 2b study of ALTO-100 in patients with major depressive disorder (MDD) did not meet its primary endpoint, assessed by a change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS), compared to placebo.” Following this news, shares of Alto Neuroscience fell by nearly 60% during after-hours trading on the same day. What's Next? If you are aware of any facts relating to this investigation or purchased Alto Neuroscience securities, you can assist this investigation by visitin
Show less
Read more
Impact Snapshot
Event Time:
ANRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANRO alerts
High impacting Alto Neuroscience, Inc. news events
Weekly update
A roundup of the hottest topics
ANRO
News
- The Schall Law Firm Wants Shareholders To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud Accesswire
- Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law FirmAccesswire
- The Schall Law Firm Invites Stockholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities FraudAccesswire
- Alto Neuroscience Inc Is Being Investigated For Violating Securities Laws And Investors With Losses Are Encouraged To Contact The Schall Law FirmAccesswire
- The Schall Law Firm Wants Shareholders To Join An Inquiry Into Alto Neuroscience, Inc. For Fraud Accesswire
ANRO
Earnings
- 11/12/24 - Beat
ANRO
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/12/24 - Form 10-Q
- ANRO's page on the SEC website